GRITSTONE ONCOLOGY, INC. STOCK PURCHASE AGREEMENTStock Purchase Agreement • February 1st, 2021 • Gritstone Oncology, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledFebruary 1st, 2021 Company Industry JurisdictionThis Stock Purchase Agreement (“Agreement”) is made as of January 29, 2021 (the “Effective Date”), by and between Gritstone Oncology, Inc., a Delaware corporation (the “Company”), and Gilead Sciences, Inc., a Delaware corporation (the “Purchaser”).
STOCKHOLDER AGREEMENT by and between GRITSTONE ONCOLOGY, INC. and GILEAD SCIENCES, INC. Dated as of January 29, 2021Stockholder Agreement • February 1st, 2021 • Gritstone Oncology, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledFebruary 1st, 2021 Company Industry JurisdictionTHIS STOCKHOLDER AGREEMENT (this “Agreement”), dated as of January 29, 2021, is by and between Gritstone Oncology, Inc., a Delaware corporation (the “Company”) and Gilead Sciences, Inc., a Delaware corporation (the “Investor”).